Ken Griffin's position in Cytokinetics is currently worth $2.37 Million. That's 0.00% of their equity portfolio (2431st largest holding). The first Cytokinetics trade was made in Q1 2014. Since then Ken Griffin bought shares 35 more times and sold shares on 37 occasions. The stake costed the investor $870 Thousand, netting the investor a gain of 172% so far.